Hepatocyte tissue factor activates the coagulation cascade in mice

Blood

Volumn 121, Issue 10, 2013, Pages 1868-1874

  Sullivan, Bradley P ^a   Kopec, Anna K ^a   Joshi, Nikita ^b   Cline, Holly ^a   Brown, Juliette A ^a   Bishop, Stephanie C ^c   Kassel, Karen M ^c   Rockwell, Cheryl ^b   Mackman, Nigel ^d   Luyendyk, James P ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; CRE RECOMBINASE; LYSINE; MESSENGER RNA; THROMBIN; THROMBOPLASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOLYSIS; LIVER CELL; LIVER HOMOGENATE; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84876488554     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-09-455436     Document Type: Article

References (37)

1. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004;24(6): 1015-1022. (Pubitemid 38737825)
2. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134(5):1087-1097. (Pubitemid 19142892)
3. Rao LV, Pendurthi UR. Regulation of tissue factor coagulant activity on cell surfaces[published online ahead of print Sep 24, 2012]. J Thromb Haemost.
4. Morrissey JH, Davis-Harrison RL, Tavoosi N, et al. Protein-phospholipid interactions in blood clotting. Thromb Res. 2010;125(Suppl 1):S23-S25.
5. Ahamed J, Versteeg HH, Kerver M, et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA. 2006;103(38):13932-13937. (Pubitemid 44452960)
6. Kothari H, Nayak RC, Rao LV, et al. Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its deencryption. Blood. 2010;115(21):4273-4283.
7. Mackman N, Sawdey MS, Keeton MR, et al. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol. 1993;143(1):76-84. (Pubitemid 24058162)
8. McCuskey RS. Morphological mechanisms for regulating blood flow through hepatic sinusoids. Liver. 2000;20(1):3-7. (Pubitemid 30095282)
9. Joist JH, George JN. Hemostatic abnormalities in liver and renal disease. In: Colman RWH, J., Marder AW, Clowes AW, and George JN, eds. Hemostasis and Thrombosis. PhilAdelphia, PA: Lippincott Williams & Wilkins; 2001:955-960.
10. Wion KL, Kelly D, Summerfield JA, et al. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature. 1985; 317(6039):726-729. (Pubitemid 16223638)
11. Willingham AK, Matschiner JT. The activation of factor X by hepatocyte plasma membranes. Cell Mol Biol. 1989;35(4):421-429. (Pubitemid 19242701)
12. St'ephenne X, Vosters O, Najimi M, et al. Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation. Liver Transpl. 2007;13(4): 599-606. (Pubitemid 46605864)
13. Ganey PE, Luyendyk JP, Newport SW, et al. Role of the coagulation system in acetaminopheninduced hepatotoxicity in mice. Hepatology. 2007; 46(4):1177-1186. (Pubitemid 350144782)
14. Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975;16(8):617-620.
15. Kerr R, Newsome P, Germain L, et al. Effects of acute liver injury on blood coagulation. J Thromb Haemost. 2003;1(4):754-759.
16. Parry GC, Erlich JH, Carmeliet P, et al. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest. 1998; 101(3):560-569. (Pubitemid 28084238)
17. Baccarani U, Adani GL, Sanna A, et al. Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient. Transpl Int. 2005;18(6):750-754. (Pubitemid 41726844)
18. Gustafson EK, Elgue G, Hughes RD, et al. The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation. Transplantation. 2011;91(6):632-638.
19. Pawlinski R, Tencati M, Holscher T, et al. Role of cardiac myocyte tissue factor in heart hemostasis. J Thromb Haemost. 2007;5(8):1693-1700. (Pubitemid 47091413)
20. Kim ND, Moon JO, Slitt AL, et al. Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci. 2006;90(2):586-595.
21. Copple BL. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxiainducible factor and transforming growth factor-beta-dependent mechanisms. Liver Int. 2010;30(5):669-682.
22. Luyendyk JP, Cantor GH, Kirchhofer D, et al. Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice. Am J Physiol Gastrointest Liver Physiol. 2009;296(4): G840-G849.
23. Khorana AA, Francis CW, Menzies KE, et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost. 2008;6(11):1983-1985.
24. Bogdanov VY, Kirk RI, Miller C, et al. Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost. 2006; 4(1):158-167.
25. Janson TL, Stormorken H, Prydz H. Species specificity of tissue thromboplastin. Haemostasis. 1984;14(5):440-444. (Pubitemid 15138626)
26. Fang CH, Lin TC, Guha A, et al. Activation of factor X by factor VIIa complexed with humanmouse tissue factor chimeras requires human exon 3. Thromb Haemost. 1996;76(3):361-368. (Pubitemid 26373528)
27. Wang JG, Manly D, Kirchhofer D, et al. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost. 2009;7(7):1092-1098.
28. Ruf W, Miles DJ, Rehemtulla A, et al. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem. 1992;267(9): 6375-6381.
29. Huang Q, Neuenschwander PF, Rezaie AR, et al. Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J Biol Chem. 1996;271(36):21752-21757. (Pubitemid 26303791)
30. Manithody C, Yang L, Rezaie AR. Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X. Biochemistry. 2007;46(11):3193-3199. (Pubitemid 46449140)
31. Roy S, Hass PE, Bourell JH, et al. Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. J Biol Chem. 1991;266(32): 22063-22066. (Pubitemid 121000289)
32. Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood. 1997;89(9): 3270-3276. (Pubitemid 27229812)
33. Furlan-Freguia C, Marchese P, Gruber A, et al. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest. 2011;121(7):2932-2944.
34. Sullivan BP, Kassel KM, Jone A, et al. Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury. Am J Pathol. 2012;180(6):2321-2329.
35. Hughes RD, Mitry RR, Dhawan A. Current status of hepatocyte transplantation. Transplantation. 2012;93(4):342-347.
36. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998;338(20):1422-1426. (Pubitemid 28221983)
37. Hoffman M, Colina CM, McDonald AG, et al. Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost. 2007;5(7):1403-1408. (Pubitemid 46965368)